Home
Scholarly Works
Characteristics of trials evaluating triple versus...
Conference

Characteristics of trials evaluating triple versus dual inhaled therapies in patients with asthma: an AAAAI/ACAAI Joint Task Force on Practice Parameters systematic review

Authors

Rayner D; Bakaa L; Rivera-Spoljaric K; Oppenheimer J; Nyenhuis S; Sumino K; Hoyte F; Israel E; Perry T; Chipps B

Volume

155

Publisher

MOSBY-ELSEVIER

Publication Date

February 1, 2025

Name of conference

American-Academy-of-Allergy-Asthma-and-Immunology/World Allergy Organization Joint Congress (AAAAI/WAO)

Conference place

CA, San Diego

Conference start date

February 28, 2025

Conference end date

March 3, 2025

Conference proceedings

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Issue

2

ISSN

0091-6749

Labels

Fields of Research (FoR)

Contact the Experts team